Ocimum Biosolutions has announced that its Biotracker Lims has been selected by the University of Texas MD Anderson Cancer Center as its standard for the automation of its Research Core Facilities.
The first facility to be automated will be the Genomics Core Facility.
MD Anderson supports a wide range of ongoing research initiatives and labs.
It required a Lims system that was robust enough to support the multiple lab environments and technologies in use today with the flexibility to handle emerging technologies.
MD Anderson also required a solution that could integrate into a variety of systems and databases in use at the institution.
The Biotracker Lims capabilities, flexibility and extensibility and its fully functional application programming interface (API) were suitable for MD Anderson's requirements.
'Ocimum's Biotracker Lims will support all our labs and integrate this system into our services-based application environment while minimising our IT footprint and internal support costs,' said Krishna Sankhavaram, director of research information systems, MD Anderson.
The first scheduled implementation will be addressing both short-term (integrity of data, managing genomic expression experiments and automation) and long-term (scalability) goals for the Genomics Core Facility.
The configurability and search capability as well as the wide array of reports that will be provided as a part of this implementation will enable the core facility to automate inventory tracking, support high throughput processing of samples, and facilitate analysis of QC data.
